AdvaMed Applauds White House Cancer Moonshot Progress
WASHINGTON, D.C. – This week, AdvaMed President and CEO Scott Whitaker welcomed progress from President Joe Biden on the White House Cancer Moonshot, including appointing new members to the President’s Cancer Cabinet and unveiling priority actions. AdvaMed member companies produce the medical devices, diagnostic tests, and health information systems that screen for, diagnose, and treat cancer.
“President Biden continues to make good on his word toward ending cancer as we know it,” Whitaker said. “His steps to enlist experts from the field and within the government and to outline priority actions are further proof of his commitment to this goal. AdvaMed and our members endorse the Cancer Moonshot as we continue our related work to bring the tremendous value of medical technology for cancer care to all patients.”
Whitaker wrote Biden in support of the Cancer Moonshot in February. AdvaMed’s own Cancer Forum brings together a wide range of medical technology companies whose products are at the heart of precision medicine and essential components in every aspect of cancer prevention and care. The Cancer Forum advocates for effective regulation, modernized coverage and payment policies, and the investment in research that are all essential for expanding patient access to essential technologies, reducing health disparities, and supporting technology innovation and high-quality care for cancer patients.
# # #